Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Walker Insider Profile
4 Followers
Charles Walker, Director at Imugene Limited, holds 22.57M shares in Imugene Limited (Ticker: IUGNF). Most recently, Charles Walker Sold $8,250,000 shares of Imugene Limited on Nov 09, 2022 for an estimated value of 1.61M.
Profitable Transactions
5 out of 9 Profitable Transactions
Average Return
-98.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Charles Walker's holdings
Insider Roles
Director
Roles that Charles Walker holds in companies
Most Profitable Insider Trade
The most profitable trade made by Charles Walker
Charles Walker's Trading History
List of latest transactions for each holding click on a transaction to see Charles Walker's performance on stock
You May Also Like
Charles Walker insider profile FAQ
What is the percentage of profitable transactions made by Charles Walker?
The percentage of profitable transactions made by Charles Walker is 56%.
What is the average return per transaction made by Charles Walker?
The average return per transaction made by Charles Walker is -98.50%.
What stocks does Charles Walker hold?
Charles Walker holds: IUGNF stocks.
What was Charles Walker’s latest transaction?
Charles Walker latest transaction was an Informative Sell of $1.61M.
What was Charles Walker's most profitable transaction?
Charles Walker’s most profitable transaction was an Informative Buy of IUGNF stock on March 25, 2020. The return on the trade was 70.80%.
What is Charles Walker's role in Imugene Limited?
Charles Walker's role in Imugene Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.